Synthesis and Characterization of New Curcumin Derivatives as Potential Chemotherapeutic and Antioxidant Agents. Issue 2 (15th November 2013)
- Record Type:
- Journal Article
- Title:
- Synthesis and Characterization of New Curcumin Derivatives as Potential Chemotherapeutic and Antioxidant Agents. Issue 2 (15th November 2013)
- Main Title:
- Synthesis and Characterization of New Curcumin Derivatives as Potential Chemotherapeutic and Antioxidant Agents
- Authors:
- Ciochina, Roxana
Savella, Chasity
Cote, Brianna
Chang, Davis
Rao, Deepa - Abstract:
- <abstract abstract-type="main"> <title>Abstract</title> <p> <table-wrap position="anchor" orientation="portrait"> <table border="1"> <colgroup span="1"> <col align="left" span="1" /> </colgroup> <tbody> <tr> <td align="left" rowspan="1" colspan="1">Preclinical Research</td> </tr> </tbody> </table> </table-wrap> </p> <p>The purpose of this work was to synthesize a series of symmetrical analogs (<bold>CA</bold><bold>2–</bold><bold>CA</bold><bold>7</bold>) of curcumin and determine their efficacy as antioxidant and anticancer agents in vitro. The six analogs were successfully synthesized and characterized, one of which, <bold>CA</bold><bold>6</bold>, had not been previously reported in the literature. With the exception of <bold>CA</bold><bold>2</bold>, the analogs had lower predicted aqueous solubilities and higher partition coefficients than curcumin. Two analogs, <bold>CA</bold><bold>2</bold> and <bold>CA</bold><bold>3</bold>, had lower potencies as anticancer agents compared with curcumin, while <bold>CA</bold><bold>6</bold> had a slightly higher IC<sub>50</sub> value. Two different trends in the antioxidant capabilities of curcumin and its analogs were determined when assessed in vitro or in cell culture. The in vitro DPPH assay clearly showed curcumin as the strongest antioxidant as compared with the analogs when tested at the same concentration or at their IC<sub>50</sub> value. The cell culture‐based reactive oxygen species/reactive nitrogen species assay indicated that<abstract abstract-type="main"> <title>Abstract</title> <p> <table-wrap position="anchor" orientation="portrait"> <table border="1"> <colgroup span="1"> <col align="left" span="1" /> </colgroup> <tbody> <tr> <td align="left" rowspan="1" colspan="1">Preclinical Research</td> </tr> </tbody> </table> </table-wrap> </p> <p>The purpose of this work was to synthesize a series of symmetrical analogs (<bold>CA</bold><bold>2–</bold><bold>CA</bold><bold>7</bold>) of curcumin and determine their efficacy as antioxidant and anticancer agents in vitro. The six analogs were successfully synthesized and characterized, one of which, <bold>CA</bold><bold>6</bold>, had not been previously reported in the literature. With the exception of <bold>CA</bold><bold>2</bold>, the analogs had lower predicted aqueous solubilities and higher partition coefficients than curcumin. Two analogs, <bold>CA</bold><bold>2</bold> and <bold>CA</bold><bold>3</bold>, had lower potencies as anticancer agents compared with curcumin, while <bold>CA</bold><bold>6</bold> had a slightly higher IC<sub>50</sub> value. Two different trends in the antioxidant capabilities of curcumin and its analogs were determined when assessed in vitro or in cell culture. The in vitro DPPH assay clearly showed curcumin as the strongest antioxidant as compared with the analogs when tested at the same concentration or at their IC<sub>50</sub> value. The cell culture‐based reactive oxygen species/reactive nitrogen species assay indicated that <bold>CA</bold><bold>3</bold> and <bold>CA</bold><bold>6</bold> were equal to curcumin in their free radical scavenging ability at the same concentration, but when curcumin and its analogs were tested at their respective IC<sub>50</sub> values, <bold>CA</bold><bold>4</bold> and <bold>CA</bold><bold>5</bold> showed excellent antioxidant capacities. These results indicate that in cell culture, the ability of these analogs to produce antioxidant effects may be tied to their downstream effects.</p> </abstract> … (more)
- Is Part Of:
- Drug development research. Volume 75:Issue 2(2014)
- Journal:
- Drug development research
- Issue:
- Volume 75:Issue 2(2014)
- Issue Display:
- Volume 75, Issue 2 (2014)
- Year:
- 2014
- Volume:
- 75
- Issue:
- 2
- Issue Sort Value:
- 2014-0075-0002-0000
- Page Start:
- 88
- Page End:
- 96
- Publication Date:
- 2013-11-15
- Subjects:
- Drug development -- Periodicals
Drugs -- Research -- Periodicals
615.19 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1098-2299 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ddr.21158 ↗
- Languages:
- English
- ISSNs:
- 0272-4391
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3629.119000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3578.xml